DEFA14A

Proxy Materials

C4 Therapeutics, Inc. Filed 2021-04-26 Acc 0001564590-21-020552

Documents 1

DEFA14A Proxy Materials , cccc-defa14a_20201231.htm

Around this filing

2022-04-29 DEFA14A Proxy Materials
2021-04-30 8-K Executive or director change
2021-04-26 DEFA14A Proxy Materials
2021-04-26 DEF 14A Proxy Statement

Link to a passage

External

SEC EDGAR (opens in new tab)